11-118901807-T-G

Variant summary

Our verdict is Likely benign. The variant received -6 ACMG points: 0P and 6B. BP4_ModerateBS2

The NM_001378213.1(BCL9L):​c.1936A>C​(p.Met646Leu) variant causes a missense change. The variant allele was found at a frequency of 0.00000411 in 1,458,418 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 16/22 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. M646V) has been classified as Benign.

Frequency

Genomes: not found (cov: 32)
Exomes 𝑓: 0.0000041 ( 0 hom. )

Consequence

BCL9L
NM_001378213.1 missense

Scores

1
18

Clinical Significance

Uncertain significance criteria provided, single submitter U:1

Conservation

PhyloP100: 5.54

Publications

6 publications found
Variant links:
Genes affected
BCL9L (HGNC:23688): (BCL9 like) Enables beta-catenin binding activity. Involved in several processes, including negative regulation of transforming growth factor beta receptor signaling pathway; positive regulation of epithelial to mesenchymal transition; and positive regulation of transcription by RNA polymerase II. Located in nucleolus and nucleoplasm. Part of beta-catenin-TCF complex. [provided by Alliance of Genome Resources, Apr 2022]

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Likely_benign. The variant received -6 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.110309064).
BS2
High AC in GnomAdExome4 at 6 AD gene.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
BCL9LNM_001378213.1 linkc.1936A>C p.Met646Leu missense_variant Exon 8 of 10 ENST00000683865.1 NP_001365142.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
BCL9LENST00000683865.1 linkc.1936A>C p.Met646Leu missense_variant Exon 8 of 10 NM_001378213.1 ENSP00000507778.1 Q86UU0-1
BCL9LENST00000334801.7 linkc.1936A>C p.Met646Leu missense_variant Exon 6 of 8 1 ENSP00000335320.3 Q86UU0-1
BCL9LENST00000526143.2 linkc.1825A>C p.Met609Leu missense_variant Exon 6 of 8 5 ENSP00000482938.1 A0A087WZX0
BCL9LENST00000530293.1 linkn.41-1046A>C intron_variant Intron 1 of 2 5

Frequencies

GnomAD3 genomes
Cov.:
32
GnomAD2 exomes
AF:
0.00000798
AC:
2
AN:
250482
AF XY:
0.00000738
show subpopulations
Gnomad AFR exome
AF:
0.00
Gnomad AMR exome
AF:
0.0000580
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.00
Gnomad OTH exome
AF:
0.00
GnomAD4 exome
AF:
0.00000411
AC:
6
AN:
1458418
Hom.:
0
Cov.:
36
AF XY:
0.00000414
AC XY:
3
AN XY:
724802
show subpopulations
African (AFR)
AF:
0.00
AC:
0
AN:
33416
American (AMR)
AF:
0.000134
AC:
6
AN:
44630
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
26060
East Asian (EAS)
AF:
0.00
AC:
0
AN:
39582
South Asian (SAS)
AF:
0.00
AC:
0
AN:
86148
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
53312
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
5760
European-Non Finnish (NFE)
AF:
0.00
AC:
0
AN:
1109312
Other (OTH)
AF:
0.00
AC:
0
AN:
60198
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.492
Heterozygous variant carriers
0
1
2
4
5
6
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
Cov.:
32
Alfa
AF:
0.00
Hom.:
56
Bravo
AF:
0.00000378

ClinVar

Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link

Submissions by phenotype

not specified Uncertain:1
May 17, 2025
Ambry Genetics
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

The c.1936A>C (p.M646L) alteration is located in exon 6 (coding exon 6) of the BCL9L gene. This alteration results from a A to C substitution at nucleotide position 1936, causing the methionine (M) at amino acid position 646 to be replaced by a leucine (L). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.093
BayesDel_addAF
Benign
-0.16
T
BayesDel_noAF
Benign
-0.29
CADD
Benign
18
DANN
Benign
0.88
DEOGEN2
Benign
0.27
T;.
Eigen
Benign
-0.45
Eigen_PC
Benign
-0.30
FATHMM_MKL
Uncertain
0.88
D
LIST_S2
Benign
0.70
T;T
M_CAP
Benign
0.015
T
MetaRNN
Benign
0.11
T;T
MetaSVM
Benign
-0.91
T
MutationAssessor
Benign
1.5
L;.
PhyloP100
5.5
PrimateAI
Benign
0.40
T
PROVEAN
Benign
-0.53
N;.
REVEL
Benign
0.13
Sift
Benign
0.25
T;.
Sift4G
Benign
0.70
T;T
Polyphen
0.0
B;.
Vest4
0.26
MutPred
0.32
Loss of catalytic residue at G647 (P = 0.2344);.;
MVP
0.53
MPC
0.19
ClinPred
0.072
T
GERP RS
3.4
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.2
Varity_R
0.057
gMVP
0.21
Mutation Taster
=96/4
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs34752197; hg19: chr11-118772516; API